TY - JOUR
T1 - Clinicopathologic Spectrum of Lysozyme-Associated Nephropathy
AU - Kudose, Satoru
AU - Cossey, L. Nicholas
AU - Canetta, Pietro A.
AU - Sekulic, Miroslav
AU - Vanbeek, Christine A.
AU - Huls, Forest B.
AU - Gupta, Isha
AU - Bu, Lihong
AU - Alexander, Mariam P.
AU - Cornell, Lynn D.
AU - Fidler, Mary E.
AU - Markowitz, Glen S.
AU - Larsen, Christopher P.
AU - D'Agati, Vivette D.
AU - Nasr, Samih H.
AU - Santoriello, Dominick
N1 - Publisher Copyright:
© 2023 International Society of Nephrology
PY - 2023/8
Y1 - 2023/8
N2 - Introduction: Lysozyme-associated nephropathy (LyN), a rare cause of kidney injury in patients with chronic myelomonocytic leukemia (CMML), has not been well described to date. We report the clinicopathologic spectrum of LyN from a multi-institutional series. Method: We identified 37 native kidney biopsies with LyN and retrospectively obtained clinicopathologic data. Results: Thirty-seven patients had a median age of 74 years and included 78% males. Their most common presentation was acute kidney injury (AKI) or AKI on chronic kidney disease (CKD) (66%) with median estimated glomerular filtration rate (eGFR) of 21.7 ml/min per 1.73 m2, and proteinuria of 1.7 g. A minority (15%) had partial Fanconi syndrome. Serum lysozyme levels were elevated in all tested. Hematologic disorder (n = 28, 76%) was the most common etiology, including CMML (n = 15), acute myeloid leukemia (n = 5), and myelodysplastic syndrome (MDS) (n = 5). Nonhematologic causes (n = 5, 14%), included metastatic neuroendocrine carcinoma (n = 3), sarcoidosis, and leprosy. Etiology was unknown in 4 (11%). Pathology showed proximal tubulopathy with abundant hypereosinophilic intracytoplasmic inclusions, with characteristic staining pattern by lysozyme immunostain. Mortality was high (8/30). However, among the 22 alive, including 85% treated, 7 had improved kidney function, including 1 who discontinued dialysis and 6 with increase in eGFR >15 ml/min per 1.73 m2 compared with eGFR at the time of biopsy. Conclusion: Increased awareness of the full clinicopathologic spectrum of LyN may lead to prompt diagnosis, earlier treatment, and potentially improved outcome of this rare entity.
AB - Introduction: Lysozyme-associated nephropathy (LyN), a rare cause of kidney injury in patients with chronic myelomonocytic leukemia (CMML), has not been well described to date. We report the clinicopathologic spectrum of LyN from a multi-institutional series. Method: We identified 37 native kidney biopsies with LyN and retrospectively obtained clinicopathologic data. Results: Thirty-seven patients had a median age of 74 years and included 78% males. Their most common presentation was acute kidney injury (AKI) or AKI on chronic kidney disease (CKD) (66%) with median estimated glomerular filtration rate (eGFR) of 21.7 ml/min per 1.73 m2, and proteinuria of 1.7 g. A minority (15%) had partial Fanconi syndrome. Serum lysozyme levels were elevated in all tested. Hematologic disorder (n = 28, 76%) was the most common etiology, including CMML (n = 15), acute myeloid leukemia (n = 5), and myelodysplastic syndrome (MDS) (n = 5). Nonhematologic causes (n = 5, 14%), included metastatic neuroendocrine carcinoma (n = 3), sarcoidosis, and leprosy. Etiology was unknown in 4 (11%). Pathology showed proximal tubulopathy with abundant hypereosinophilic intracytoplasmic inclusions, with characteristic staining pattern by lysozyme immunostain. Mortality was high (8/30). However, among the 22 alive, including 85% treated, 7 had improved kidney function, including 1 who discontinued dialysis and 6 with increase in eGFR >15 ml/min per 1.73 m2 compared with eGFR at the time of biopsy. Conclusion: Increased awareness of the full clinicopathologic spectrum of LyN may lead to prompt diagnosis, earlier treatment, and potentially improved outcome of this rare entity.
KW - chronic myelomonocytic leukemia
KW - granulomas
KW - kidney biopsy
KW - lysozyme
KW - lysozyme induced nephropathy
KW - proximal tubulopathy
UR - http://www.scopus.com/inward/record.url?scp=85160686379&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85160686379&partnerID=8YFLogxK
U2 - 10.1016/j.ekir.2023.05.007
DO - 10.1016/j.ekir.2023.05.007
M3 - Article
AN - SCOPUS:85160686379
SN - 2468-0249
VL - 8
SP - 1585
EP - 1595
JO - Kidney International Reports
JF - Kidney International Reports
IS - 8
ER -